Novadiscovery announces key collaboration with Janssen France to provide in silico based decision support for clinical development
Continue reading here:
Novadiscovery announces key collaboration with Janssen France to provide in silico based decision support for clinical development
GHENT, Belgium, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces that its management team will participate in two upcoming virtual investor conferences, being held in parallel with the JP Morgan 39th Annual Healthcare Conference.
See original here:
Sequana Medical Announces January 2021 Investor Conference Schedule
COPENHAGEN, Denmark, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the appointment of previously practicing commercial, technology and corporate lawyer Marianne Søgaard as Chairwoman of the Board of Directors.
Read the original here:
Evaxion Biotech Appoints Marianne Søgaard as Chairwoman
Guerbet makes the CDP A grade1 for its commitment to the fight against global warming
See the rest here:
Guerbet makes the CDP A grade for its commitment to the fight against global warming
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
ARESTAT™ formulated product progressing into clinical trial ARESTAT™ formulated product progressing into clinical trial
Go here to see the original:
Arecor's Partner Inhibrx Exercises Its Option to License a New Formulation Developed by Arecor in Accordance With the Terms of Formulation Development...
Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody targeting TA-MUC1
Publication of Supplementary Prospectus
See the article here:
Publication of Supplementary Prospectus